October 13, 2026 11:00AM-12:00PM CT
The Loyalty Gap: What 601 Employers and 300 Advisors Told Us About Pharmacy Benefits in 2026
Costs keep climbing, specialty and GLP-1 drug spend are reshaping every renewal, and new transparency laws are giving employers fresh reasons to question relationships they once took for granted. Switching advisors hasn’t solved the problem — it hasn’t even slowed rising costs.
This panel breaks down what it actually takes to prove value, build trust, and win in a market that rewards proof over positioning based on proprietary data we gathered by surveying hundreds of advisors and employers
What You’ll Learn:
- Defend your value with proof and clear accountability, not narrative
- Explain why transparency alone won’t lower net cost
- Frame balanced, multi-dimensional recommendations that hold up under scrutiny
- Help clients judge who can manage specialty, biosimilar, and GLP-1 trend — not just report on it
- Show clients how the PBO model drives ongoing optimization instead of endless replacement
Presented By
Kyra Hagan Moderator | SVP, Marketing and Communications
Bradley Nelson VP, Clinical Services
Jasmine Aral SVP, PBM Strategy & Partnerships
